feed,title,long_url,short_url
MedRxiv,Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens,https://medrxiv.org/cgi/content/short/2022.08.02.22278342v1?rss=1,https://bit.ly/3zUxWGm
MedRxiv,COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review,https://medrxiv.org/cgi/content/short/2022.08.03.22278359v1?rss=1,https://bit.ly/3buAWQC
MedRxiv,Geospatial disparities in federal COVID-19 test-to-treat program,https://medrxiv.org/cgi/content/short/2022.08.02.22278349v1?rss=1,https://bit.ly/3BFbYZj
